Botanical species · safety record

Buxus sempervirens

The EFSA Compendium of Botanicals holds 20 constituent measurements for Buxus sempervirens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Buxus sempervirens L.

20Constituent measurements
0Safety records
11Cited sources
4Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 4 licensed products naming Buxus sempervirens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Jeunes pousses
  • Leaf
  • Twig(s)
  • Young leaves and twigs
  • Young shoots

What the records describe

Constituents measured

  • Steroidal alkaloids9
  • Alkaloids3
  • Coumarins1
  • Cyclobuxine1
  • Hydroquinone1
  • Imperialine1
  • Lutein epoxide1
  • Saponins1
  • Tannins1
  • Triterpene alkaloids1

Plant parts

  • Leaves10
  • Roots and other underground parts3
  • Unspecified3
  • Wood3
  • Bud1

Preparations

  • Solvent extraction19

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extractionHPLC-MS/MSResolve DOI
ImperialineLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal alkaloidsWoodSolvent extraction66 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal alkaloidsLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal alkaloidsWoodSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal alkaloidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal alkaloidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal alkaloidsLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal alkaloidsWoodSolvent extraction24 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
Steroidal alkaloidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Triterpene alkaloidsUnspecifiedSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
AlkaloidsUnspecifiedSolvent extraction≥ 1 PercentChromatographic testsNo resolvable identifier
AlkaloidsUnspecifiedSolvent extraction≤ 35 PercentChromatographic testsNo resolvable identifier
CoumarinsLeavesSolvent extractionUnspecifiedNo resolvable identifier
CyclobuxineLeavesSolvent extractionUnspecifiedNo resolvable identifier
HydroquinoneLeavesSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
Lutein epoxideBud10 MillimoleFluorimetry, Nephelometry and PolarimetryNo resolvable identifier
SaponinsLeavesSolvent extractionUnspecifiedNo resolvable identifier
Steroidal alkaloidsLeavesSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
TanninsLeavesSolvent extractionUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Liu, Hai-Feng., Ji, Min., Cai, Jin. Short and efficient approach towards buxozine-C, an alkaloid from Buxus sempervirens . Archiv der pharmazie, 2006, vol. 339, no. 12, p. 675-676. DOI
  2. Eshonov, M. A., Turgunov, K. K., Tashkhodzhaev, B., Shakirov, R. Alkaloids of Buxus sempervirens, Crystal and Molecular Structure of Cyclobuxine-D and Imperialine . Chemistry of natural compounds, 2014, vol. 49, no. 6, p. 1179-1182. DOI
  3. ATTAURRAHMAN., AHMED, D., ASIF, E., JAMAL, SA., CHOUDHARY, MI., SENER, B., TURKOZ, S. STEROIDAL ALKALOIDS FROM LEAVES OF BUXUS-SEMPERVIRENS. Phytochemistry, 1991, vol. 30, no. 4, p. 1295-1298.
  4. Atta-ur-Rahman., Ata, A., Naz, S., Choudhary, MI., Sener, B., Turkoz, S. New steroidal alkaloids from the roots of Buxus sempervirens. Journal of natural products, 1999, vol. 62, no. 5, p. 665-669. DOI
  5. AttaurRahman., Choudhary, MI., Naz, S., Ata, A., Sener, B., Turkoz, S. New steroidal alkaloids from the roots of Buxus sempervirens. Journal of natural products, 1997, vol. 60, no. 8, p. 770-774. DOI
  6. Choudhary, M. Iqbal., Shahnaz, Salma., Parveen, Shehnaz., Khalid, Asaad., Mesaik, M. Ahmed., Ayatollahi, S. Abdul Majeed., Atta-ur-Rahman. New cholinesterase-inhibiting triterpenoid alkaloids from Buxus hyrcana. Chemistry & biodiversity, 2006, vol. 3, no. 9, p. 1039-1052. DOI
  7. Ghodsi, M. R., Netien, G. Presence of arbutoside in the leaves of Buxus sempervirens. Bulletin des travaux de la societe de pharmacie de lyon, 1970, vol. 14, no. 4, p. 115-18.
  8. Garcia-Plazaola, Jose I., Hormaetxe, Koldobika., Hernandez, Antonio., Olano, Jose M., Becerril, Jose M. The lutein epoxide cycle in vegetative buds of woody plants. Functional plant biology, 2004, vol. 31, no. 8, p. 815-823.
  9. Brown, Jr., K.S., Kupchan, S.M. A convenient separation of alkaloid mixtures by partition chromatography, using an indicator in the stationary phase. Journal of chromatography a, 1962, vol. 9, no. C, p. 71-80.
  10. Orazmuradov, G. M., Karryev, M. O. Chemical composition of Buxus sempervirens leaves. Izvestiya akademii nauk turkmenskoi ssr, seriya biologicheskikh nauk, 1974, vol. (6), p. 71-3.
  11. Leuthardt, Florine L. G., Glauser, Gaetan., Baur, Bruno. Composition of alkaloids in different box tree varieties and their uptake by the box tree moth Cydalima perspectalis . Chemoecology, 2013, vol. 23, no. 4, p. 203-212. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue